Patent · US Expired

Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients

US7309497B2 · kind B2 · utility

30Cited by

169References

29Claims

0Family size

Assignee

Schwarz Pharma Ltd. · DE

Inventors

Stephan Rimpler · Hilden, DE
Sabine Grapatin · Langenfeld, DE
Cliff Krein · Overath, DE
Markus Thelen · Monheim, DE

Key dates

Filing date	Aug 21, 2001
Grant date	Dec 18, 2007
Priority date	—
Expiry date	May 27, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient in a solid phase, (b) a vehicle consisting substantially of polyol fatty acid esters with a degree of esterification of over 80%, and (c) a wetting agent consisting substantially of polyol fatty acid esters with a monoester proportion of over 60%. The inventive composition is used for the systemic administration of numerous pharmacologically active ingredients, whereby the ingredients are released from the pharmaceutical composition over a period of at least 12, preferably at least 24 hours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.